ALK-Abello A-S

Headquarters: Horsholm, Denmark

Employees: 2,537

CEO: Mr. Carsten Hellmann

OMXC: ALK.B +2.46%

Market Cap

kr.23.07 Billion

DKK as of Jan. 1, 2024

US$3.42 Billion

Market Cap History

ALK-Abello A-S market capitalization over time

Evolution of ALK-Abello A-S market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of ALK-Abello A-S

Detailed Description

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

Top 1-year algo backtest: +181.22%

$10,000 in June 2023 would now be $28,122 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

ALK-Abello A-S has the following listings and related stock indices.

Stock: OMXC: ALK.B wb_incandescent

Stock: FSX: 4AJ wb_incandescent



Boge Alle 6-8

Horsholm, 2970


Phone: 45 45 74 75 76

Fax: 45 45 74 86 90